Ixazomib with chemotherapy for childhood relapsed acute lymphoblastic leukemia: a TACL consortium report.

Schafer ES, Pacenta HL, Chi YY, Malvar J, Doan A, Schore RJ, Rushing T, Leong R, Bujarski S, Gaynon PS, Karol SE, Barredo JC, Rheingold SR, Huynh V, Gossai NP, Chang BH, Slone T, Pauly M, Wayne AS, Bhojwani D, Horton TM

Open source

DOI: 10.1016/j.bneo.2026.100247
Published: 2026 Aug
Container: Blood neoplasia
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.bneo.2026.100247,
  title = {Ixazomib with chemotherapy for childhood relapsed acute lymphoblastic leukemia: a TACL consortium report.},
  author = {Schafer ES and Pacenta HL and Chi YY and Malvar J and Doan A and Schore RJ and Rushing T and Leong R and Bujarski S and Gaynon PS and Karol SE and Barredo JC and Rheingold SR and Huynh V and Gossai NP and Chang BH and Slone T and Pauly M and Wayne AS and Bhojwani D and Horton TM},
  year = {2026},
  journal = {Blood neoplasia},
  doi = {10.1016/j.bneo.2026.100247},
  url = {https://doi.org/10.1016/j.bneo.2026.100247}
}

RIS

TY  - JOUR
TI  - Ixazomib with chemotherapy for childhood relapsed acute lymphoblastic leukemia: a TACL consortium report.
AU  - Schafer ES
AU  - Pacenta HL
AU  - Chi YY
AU  - Malvar J
AU  - Doan A
AU  - Schore RJ
AU  - Rushing T
AU  - Leong R
AU  - Bujarski S
AU  - Gaynon PS
AU  - Karol SE
AU  - Barredo JC
AU  - Rheingold SR
AU  - Huynh V
AU  - Gossai NP
AU  - Chang BH
AU  - Slone T
AU  - Pauly M
AU  - Wayne AS
AU  - Bhojwani D
AU  - Horton TM
PY  - 2026
JO  - Blood neoplasia
DO  - 10.1016/j.bneo.2026.100247
UR  - https://doi.org/10.1016/j.bneo.2026.100247
ER  -

APA

ES, S., HL, P., YY, C., J, M., A, D., RJ, S., T, R., R, L., S, B., PS, G., SE, K., JC, B., SR, R., V, H., NP, G., BH, C., T, S., M, P., AS, W., D, B., & TM, H. (2026). Ixazomib with chemotherapy for childhood relapsed acute lymphoblastic leukemia: a TACL consortium report.. Blood neoplasia. https://doi.org/10.1016/j.bneo.2026.100247

Source records

pubmed · retrieved 2026-09-26T12:07:07.347Z